In the context of cancer, alternative splicing plays a crucial role in the development and progression of the disease. Aberrations in splicing mechanisms can lead to the production of protein isoforms that promote tumor growth, evade apoptosis, or enhance metastasis. These splicing events can affect oncogenes, tumor suppressor genes, and other regulatory proteins involved in cell cycle control and DNA repair.
